Melinta Therapeutics Highlighting Activity of Baxdela as well as Progress on Macrolide and Pyrrolocytosine Candidates at ECCMID 2017

World News: . []

New Haven Conn April 19 2017 GLOBE NEWSWIRE -- Melinta Therapeutics a privately held company developing novel antibiotics to treat serious bacterial infections announced today that there will be nine presentations on Melinta programs at the 27th E...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 19:43 GMT Wednesday 19th April 2017

Published: .

Search for other references to "melinta" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers